Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,191,320
in 3 filings, $2.1M under 10b5-1 plans

Net −$2,191,320. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-19 Tade Brad L. CFO and Treasurer Shares withheld for taxes −6,479 $16.32 $106K 232,940
2025-07-24 Tade Brad L. CFO and Treasurer Shares withheld for taxes −7,123 $17.31 $123K 239,419
2025-06-26 Tade Brad L. CFO and Treasurer Shares withheld for taxes −9,838 $18.40 $181K 246,542
2025-02-26 Tade Brad L. CFO and Treasurer Shares withheld for taxes −5,280 $15.78 $83K 256,380
2025-02-19 Tade Brad L. CFO and Treasurer Grant or award +62,227 261,660
2025-02-19 Tade Brad L. CFO and Treasurer Grant or award · Stock Option (right to buy) +93,023 93,023
2024-11-22 Tade Brad L. CFO and Treasurer Sale −15,000 $21.15 $317K 199,433
2024-07-24 Tade Brad L. CFO and Treasurer Grant or award +72,400 214,433
2024-07-24 Tade Brad L. CFO and Treasurer Grant or award · Stock Option (right to buy) +115,100 115,100

Page 1 of 1 · 9 trades